{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-001345","form_type":"8-K/A","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2022-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.375470+00:00","generated_at":"2026-06-27T04:13:17.251422+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Joint Corp. reports 38% revenue growth in FY2021; corrects 2022 clinic opening guidance to 110-130","bullets":["Q4 revenue $22.4M (+32% YoY); net income $224K vs $10.6M (prior year benefitted from $8.9M tax valuation allowance reversal).","Full-year revenue $81.2M (+38%); Adjusted EBITDA $13.3M (+46%); system-wide comp sales +29%.","Opened 130 clinics in 2021 (110 franchised, 20 greenfield); total clinics 706 at year-end.","2022 guidance: revenue $102-106M, Adjusted EBITDA $15-17M; franchised openings corrected to 110-130 from 130-140.","Cash $19.5M at Dec 31, 2021; sold 156 franchise licenses in 2021 vs 121 in 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-001345","json":"https://secwatch.observer/filing/0001171843-22-001345.json","markdown":"https://secwatch.observer/filing/0001171843-22-001345.md","text":"https://secwatch.observer/filing/0001171843-22-001345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322001345/0001171843-22-001345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322001345/f8ka_022522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:13:17.251422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}